Zions Bancorporation, National Association’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$709K Buy
+3,738
New +$703K 0.04% 202
2026
Q1
Sell
-11,176
Closed -$2.05M 1537
2025
Q4
$2.05M Buy
11,176
+226
+2% +$39.6K 0.09% 144
2025
Q3
$1.68M Buy
10,950
+177
+2% +$26.8K 0.08% 165
2025
Q2
$1.51M Buy
10,773
+128
+1% +$17.9K 0.08% 195
2025
Q1
$1.56M Buy
+10,645
New +$1.54M 0.1% 176

Other funds holding AZN

Zions Bancorporation, National Association's AZN Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in AstraZeneca (AZN) in Q2 2026: 3,738 shares worth $709K. The stake represents 0.04% of the portfolio and ranks #202 among its holdings. This is a return to the name: Zions Bancorporation, National Association previously reported a position in AZN as recently as Q4 2025.

Zions Bancorporation, National Association first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.05M in Q4 2025. 1,149 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Zions Bancorporation, National Association held 3,738 shares of AstraZeneca worth $709K as of Q2 2026.
  • AstraZeneca was a new Zions Bancorporation, National Association position in Q2 2026.
  • AstraZeneca made up 0.04% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #202 holding.
  • Zions Bancorporation, National Association first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
  • Zions Bancorporation, National Association's AstraZeneca position peaked at $2.05M in Q4 2025.
  • 1,149 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.